(Q40097601)

English

Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships

scientific article published on 3 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

El Houda Agueznay N

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Badoual C

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hans S

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Gey A

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Vingert B

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Peyrard S

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Quintin-Colonna F

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Ravel P

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Bruneval P

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Roncelin S

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Lelongt B

11

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Bertoglio J

12

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Fridman WH

13

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Brasnu D

14

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Tartour E

15

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

3 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

150

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

114-123

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Metalloproteinases and their inhibitors in tumor angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Extracellular matrix remodelling: the role of matrix metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

How matrix metalloproteinases regulate cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

A novel role of metalloproteinase in cancer-mediated immunosuppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Structural biochemistry and activation of matrix metalloproteases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

The released interleukin 2 receptor binds interleukin 2 efficiently

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Cellular source of soluble interleukin 2 receptors in serum of mice after recombinant interleukin 2 administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

30 August 2018

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219282

2 December 2018

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin-2 receptor levels in patients with malignant melanoma and renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum soluble interleukin-2 receptor in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum soluble interleukin–2 receptor concentrations as an independent prognostic marker in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-9: marker or mediator of tissue damage in asthma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 receptors in pulmonary adenocarcinoma tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental metastasis is suppressed in MMP-9-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17680822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2007.03464.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40097601&oldid=1885247492"